Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
AXOVANT GENE THERAPIES LTD
CUSIP: G0750W203
Class: COM
D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)
Note: Option positions (PUT/CALL) are excluded.
Q2 2020
Shares
161,702
Value ($000)
$456
Avg Close
—
Range
—
Q1 2020
Shares
94,843
Value ($000)
$231
Avg Close
—
Range
—
Q4 2019
Shares
25,093
Value ($000)
$128
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q2 2020
161,702
$456
—
—
Q1 2020
94,843
$231
—
—
Q4 2019
25,093
$128
—
—